Tobacco Cessation Intervention

Smoking Tobacco Clinical Trial

Official title:

Educational Interventions to Promote Tobacco Cessation Among Women Seeking Mammography Screening

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03657511
• Other study ID #: 2018-006
• Status: Completed
• Phase: N/A
• Start date: October 22, 2018
• Est. completion date: June 21, 2021

Study information

• Verified date: May 2022
• Source: Barbara Ann Karmanos Cancer Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is planned as an evaluation of a low cost, simple smoking cessation intervention. There is very little information about the effectiveness of a simple tobacco cessation strategy. Therefore, our objective is to obtain estimates of effectiveness that can be used to refine existing programs or to develop new ones.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: June 21, 2021
• Est. primary completion date: June 21, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Able to understand and read English

Exclusion Criteria:

• Currently undergoing tobacco cessation treatment

Related Conditions & MeSH terms

• Smoking Tobacco

Intervention

Behavioral:
• Educational Interventions to Promote Tobacco Cessation
Women receiving a screening mammogram at KCI downtown and McLaren Macomb, will be given a self-administered questionnaire at check-in. Women who indicate they are current smokers are eligible for the study. After the screening mammogram is complete, eligible women will be consented. Educational materials will be provided to the participant at that time. The materials provided outline evidence-based approaches to smoking cessation and include contact information for local resources including cessation support groups, Michigan Tobacco Quitline, American Cancer Society's Guide to Quitting Smoking, Quitnet, Smokfree.gov and Become An Ex. The participant will be contacted by telephone approximately 12 weeks later to determine if she is currently smoking or had quit in the last 12 weeks.

Locations

Country	Name	City	State
United States	Barbara Ann Karmanos Cancer Institute	Detroit	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
Barbara Ann Karmanos Cancer Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The number of women who quit smoking in the last 12 weeks	Completion of second questionnaire to determine if participant is currently smoking or had quit smoking in the last 12 weeks.	12 weeks after initial self-administered questionnaire
Secondary	The number of women who attempted to quit smoking in the last 12 weeks.	Completion of second questionnaire to determine if participant is currently smoking or had quit smoking in the last 12 weeks.	12 weeks after initial self-administered questionnaire